Amyloid Designed to Inactivate Cancer-Related Protein

Researchers build a peptide that causes a receptor to form toxic, amyloid-like clumps in cells.

By | November 14, 2016

VEGFR2 bound by axitinibWIKIMEDIA, FUSE809Scientists have designed a peptide that homes in on an amyloid-vulnerable region of a protein involved in cancer, causing the molecule to aggregate and deactivate. The resulting protein clumps were toxic to cells—but only those that rely on the protein’s activity. The team published its findings in Science last week (November 11).

“Although we don’t yet know if functional amyloids could be used in humans for therapeutic applications, the potential for novel drugs is huge,” study coauthor Joost Schymkowitz of the University of Leuven, Belgium, said in a press release. “Our team will now spend the coming years trying to turn this into direct benefits for patients.”

With its designer peptide, called vascin, Schymkowitz’s group targeted vascular endothelial growth factor receptor (VEGFR2)—specifically, an “amyloidogenic sequence” within the protein. Although VEGFR2 doesn’t normally form amyloids, the designer peptide’s interaction with this vulnerable region caused VEGFR2 to snarl.

“We found vascin only to be toxic to cells that are dependent on VEGFR2 function, suggesting that toxicity is due to loss of VEGFR2 function and not to vascin aggregation or vascin-induced VEGFR2 aggregation,” Schymkowitz and his colleagues wrote in their report.

Speaking with STAT News, Schymkowitz said amyloid-inducing peptides could be deployed for combatting various diseases. “Because these principles apply to virtually any protein, our approach may not only be useful in developing future cancer therapies, but also in treating drug-resistant infections.” 

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  2. Two Dozen House Republicans Do an About-Face on Tuition Tax
  3. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  4. The Biggest DNA Origami Structures Yet
    Daily News The Biggest DNA Origami Structures Yet

    Three new strategies for using DNA to generate large, self-assembling shapes create everything from a nanoscale teddy bear to a nanoscale Mona Lisa.